Unihealth Hospitals Ratios

Unihealth Hospitals Ltd Ratios

The Unihealth Hospitals Ltd Ratios page provides a complete fundamental analysis of Unihealth Hospitals Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Unihealth Hospitals Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Unihealth Hospitals Ltd (NSE: UNIHEALTH, BSE: 91654) is currently trading at ₹393.95, with a market capitalization of ₹5.87B. As a major player in the Health services sector and Medical/Nursing services industry, Unihealth Hospitals Ltd remains a key stock for fundamental analysis using Unihealth Hospitals Ltd Ratios.

Unihealth Hospitals Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Unihealth Hospitals Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Unihealth Hospitals Ltd Ratios.

Historically, the Unihealth Hospitals Ltd P/E ratio has shown strong fluctuations:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0
• 2020: 0

The decline in Unihealth Hospitals Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Unihealth Hospitals Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.

Historical P/B trend:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Unihealth Hospitals Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Unihealth Hospitals Ltd P/S ratio currently stands at 0, an important part of Unihealth Hospitals Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

A stable or declining Unihealth Hospitals Ltd P/S ratio indicates cautious market sentiment.

Unihealth Hospitals Ltd Price to Cash Flow Ratio (P/CF)

The Unihealth Hospitals Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Unihealth Hospitals Ltd Price to Cash Flow Ratio:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0
• 2020: 0

The declining Unihealth Hospitals Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Unihealth Hospitals Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Unihealth Hospitals Ltd EV currently stands at ₹0, representing the total company valuation including debt.

Historical EV trend:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Unihealth Hospitals Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Unihealth Hospitals Ltd EV/EBITDA ratio is currently 0, a key metric in Unihealth Hospitals Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Stable Unihealth Hospitals Ltd EV/EBITDA indicates balanced valuation.

Unihealth Hospitals Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Unihealth Hospitals Ltd D/E ratio is currently 0.13, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.13
• 2023: 0.18
• 2022: 1.43
• 2021: 2.57

Unihealth Hospitals Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Unihealth Hospitals Ltd ROE currently stands at 16.03%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 16.03
• 2023: 18.25
• 2022: 36.30
• 2021: 29.97

Unihealth Hospitals Ltd maintains stable profitability levels.

Unihealth Hospitals Ltd Ratios Analysis Summary

The Unihealth Hospitals Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Unihealth Hospitals Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Unihealth Hospitals Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.